Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Mutch

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Expert Review of Anticancer Therapy|March 22, 2016
The clinical management of inoperable endometrial carcinomaMarguerite Palisoul, David G Mutch
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Pathology of cancers of the female genital tract including molecular pathologyJaime Prat, David G Mutch
Gynecologic Oncology|June 1, 2014
2014 FIGO staging for ovarian, fallopian tube and peritoneal cancerDavid G Mutch, Jaime Prat
Women'S Health (London, England)|June 24, 2014
Update on prognostic markers for endometrial cancerPratibha S Binder, David G Mutch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Endometrial Tumor Immune Response: Predictive Biomarker of Response to ImmunotherapyMary M Mullen, David G Mutch
Cancer|January 7, 2017
The promise of molecular staging for the futureGeorge Larry Maxwell, David G Mutch
Gynecologic Oncology|August 21, 2003
Gemcitabine in cervical cancerDavid G Mutch, Jeffrey D Bloss
Gynecologic Oncology|March 16, 2018
Lymphnode staging update in the American Joint Committee on Cancer 8th Edition cancer staging manualAlexander B Olawaiye, David G Mutch
Journal of the American College of Surgeons|April 16, 2025
Opportunistic Salpingectomy: A Call to Implementation Science Arms to Prevent Ovarian CancerAndrea R Hagemann, David G Mutch
Clinical Obstetrics and Gynecology|September 16, 2003
Treatment of high-risk gestational trophoblastic tumorsJason D Wright, David G Mutch
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Expert Review of Anticancer Therapy|March 22, 2016
The clinical management of inoperable endometrial carcinomaMarguerite Palisoul, David G Mutch
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Pathology of cancers of the female genital tract including molecular pathologyJaime Prat, David G Mutch
Gynecologic Oncology|June 1, 2014
2014 FIGO staging for ovarian, fallopian tube and peritoneal cancerDavid G Mutch, Jaime Prat
Women'S Health (London, England)|June 24, 2014
Update on prognostic markers for endometrial cancerPratibha S Binder, David G Mutch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Endometrial Tumor Immune Response: Predictive Biomarker of Response to ImmunotherapyMary M Mullen, David G Mutch
Cancer|January 7, 2017
The promise of molecular staging for the futureGeorge Larry Maxwell, David G Mutch
Gynecologic Oncology|August 21, 2003
Gemcitabine in cervical cancerDavid G Mutch, Jeffrey D Bloss
Gynecologic Oncology|March 16, 2018
Lymphnode staging update in the American Joint Committee on Cancer 8th Edition cancer staging manualAlexander B Olawaiye, David G Mutch
Journal of the American College of Surgeons|April 16, 2025
Opportunistic Salpingectomy: A Call to Implementation Science Arms to Prevent Ovarian CancerAndrea R Hagemann, David G Mutch
Clinical Obstetrics and Gynecology|September 16, 2003
Treatment of high-risk gestational trophoblastic tumorsJason D Wright, David G Mutch
Pageof 30